These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 37173915)

  • 21. The Interplay Between Inflammation and Stromal Components in Pancreatic Cancer.
    Li Y; Wang J; Wang H; Zhang S; Wei Y; Liu S
    Front Immunol; 2022; 13():850093. PubMed ID: 35493517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated clinical analysis and data mining assessed the impact of NOX4 on the immune microenvironment and prognosis of pancreatic cancer.
    Zhao X; He Y; Pan Y; Ye L; Liu L; Mou X; Fu L
    Front Oncol; 2023; 13():1044526. PubMed ID: 36874093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy of pancreatic cancer.
    Sunami Y; Kleeff J
    Prog Mol Biol Transl Sci; 2019; 164():189-216. PubMed ID: 31383405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.
    Mierke CT
    Rep Prog Phys; 2019 Jun; 82(6):064602. PubMed ID: 30947151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study).
    Heinrich S; Pestalozzi B; Lesurtel M; Berrevoet F; Laurent S; Delpero JR; Raoul JL; Bachellier P; Dufour P; Moehler M; Weber A; Lang H; Rogiers X; Clavien PA
    BMC Cancer; 2011 Aug; 11():346. PubMed ID: 21831266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells.
    Mota Reyes C; Teller S; Muckenhuber A; Konukiewitz B; Safak O; Weichert W; Friess H; Ceyhan GO; Demir IE
    Clin Cancer Res; 2020 Jan; 26(1):220-231. PubMed ID: 31585935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting inflammation in pancreatic cancer: Clinical translation.
    Steele CW; Kaur Gill NA; Jamieson NB; Carter CR
    World J Gastrointest Oncol; 2016 Apr; 8(4):380-8. PubMed ID: 27096033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting tumor-associated macrophages to combat pancreatic cancer.
    Cui R; Yue W; Lattime EC; Stein MN; Xu Q; Tan XL
    Oncotarget; 2016 Aug; 7(31):50735-50754. PubMed ID: 27191744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.
    Liu W; Vivian CJ; Brinker AE; Hampton KR; Lianidou E; Welch DR
    Cancer Microenviron; 2014 Dec; 7(3):117-31. PubMed ID: 24938990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects].
    Ye C; Zheng L; Yuan CH
    Zhonghua Wai Ke Za Zhi; 2019 Jan; 57(1):10-15. PubMed ID: 30612387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highlights on the Role of
    Hafezi S; Saber-Ayad M; Abdel-Rahman WM
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment.
    van Roessel S; van Veldhuisen E; Klompmaker S; Janssen QP; Abu Hilal M; Alseidi A; Balduzzi A; Balzano G; Bassi C; Berrevoet F; Bonds M; Busch OR; Butturini G; Del Chiaro M; Conlon KC; Falconi M; Frigerio I; Fusai GK; Gagnière J; Griffin O; Hackert T; Halimi A; Klaiber U; Labori KJ; Malleo G; Marino MV; Mortensen MB; Nikov A; Lesurtel M; Keck T; Kleeff J; Pandé R; Pfeiffer P; Pietrasz D; Roberts KJ; Sa Cunha A; Salvia R; Strobel O; Tarvainen T; Bossuyt PM; van Laarhoven HWM; Wilmink JW; Groot Koerkamp B; Besselink MG;
    JAMA Oncol; 2020 Nov; 6(11):1733-1740. PubMed ID: 32910170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour microenvironment and heterotypic interactions in pancreatic cancer.
    Velasco RM; García AG; Sánchez PJ; Sellart IM; Sánchez-Arévalo Lobo VJ
    J Physiol Biochem; 2023 Feb; 79(1):179-192. PubMed ID: 35102531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological Gene Signature Associated With the Tumor Microenvironment of Pancreatic Cancer After Neoadjuvant Chemotherapy.
    Hane Y; Tsuchikawa T; Nakamura T; Hatanaka KC; Saito T; Tanaka K; Nakanishi Y; Asano T; Noji T; Okamura K; Shichinohe T; Yokota I; Hatanaka Y; Hirano S
    Pancreas; 2020 Oct; 49(9):1240-1245. PubMed ID: 32898010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T-cell programming in pancreatic adenocarcinoma: a review.
    Seo YD; Pillarisetty VG
    Cancer Gene Ther; 2017 Mar; 24(3):106-113. PubMed ID: 27910859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current Systemic Treatment and Emerging Therapeutic Strategies in Pancreatic Adenocarcinoma.
    Yee NS; Kazi AA; Yee RK
    Curr Clin Pharmacol; 2015; 10(4):256-66. PubMed ID: 26548903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive analysis of prognostic value and immune infiltration of CXC chemokines in pancreatic cancer.
    Jing Y; Wang F; Zhang K; Chen Z
    BMC Med Genomics; 2022 Apr; 15(1):96. PubMed ID: 35468838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor microenvironment participates in metastasis of pancreatic cancer.
    Ren B; Cui M; Yang G; Wang H; Feng M; You L; Zhao Y
    Mol Cancer; 2018 Jul; 17(1):108. PubMed ID: 30060755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant immunotherapy is reshaping cancer management across multiple tumour types: The future is now!
    Maio M; Blank C; Necchi A; Di Giacomo AM; Ibrahim R; Lahn M; Fox BA; Bell RB; Tortora G; Eggermont AMM
    Eur J Cancer; 2021 Jul; 152():155-164. PubMed ID: 34107449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neoadjuvant treatment of primarily resectable and borderline resectable pancreatic cancer].
    Scheufele F; Friess H
    Chirurg; 2020 May; 91(5):391-395. PubMed ID: 31965198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.